4031 - 4040 of 7939 Results
Title
Year
- Neuro‐oxysterols and neuro‐sterols as ligands to nuclear receptors, GPCRs, ligand‐gated ion channels and other protein receptors2020RESTRICTEDTitle: Neuro‐oxysterols and neuro‐sterols as ligands to nuclear receptors, GPCRs, ligand‐gated ion channels and other protein receptorsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 178Issue #: 16Start Page: 3176End Page: 3193Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.15191Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15191Citation Count: 21
-
OPENTitle: Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adultsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010596Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713747Citation Count: 36
- Developing a family engagement plan for Native Hawaiian and Pacific IslanderSTEMstudents in higher education: A review and critique of the literature2020RESTRICTEDTitle: Developing a family engagement plan for Native Hawaiian and Pacific IslanderSTEMstudents in higher education: A review and critique of the literatureJournal Name: Asia Pacific ViewpointPublisher: WileyVol: 62Issue #: 1Start Page: 86End Page: 99Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific, author manuscript, publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/apv.12288Best OA location URL: https://rss.onlinelibrary.wiley.com/doi/am-pdf/10.1111/apv.12288Citation Count: 6
- Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID‐19 patients2020OPENTitle: Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID‐19 patientsJournal Name: International Forum of Allergy & RhinologyPublisher: WileyVol: 10Issue #: 10Start Page: 1127End Page: 1135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alr.22680Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436559Citation Count: 92
- Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era2020RESTRICTEDTitle: Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine eraJournal Name: Medicinal Research ReviewsPublisher: WileyVol: 40Issue #: 6Start Page: 2650End Page: 2681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/med.21718Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/med.21718Citation Count: 33
-
RESTRICTEDTitle: Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approachesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1047End Page: 1064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1800454Citation Count: 12
- Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity2020OPENTitle: Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-01004-6Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-01004-6Citation Count: 17
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 8
-
OPENTitle: Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2174End Page: 2183Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28220Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28220Citation Count: 29
- The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease2020OPENTitle: The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01874-2Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-020-01874-2Citation Count: 11